Noncontraceptive estrogen use and cardiovascular disease.
about
Research on coronary disease in women: political or scientific imperative?The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women.17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.Hormonal modulation of endothelial NO production.Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbitsPreventive medicine and public health: preventing osteoporosis.Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists.Biological assessments in female reproductive toxicologyCongress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular diseaseOestrogens and cardiovascular diseasePathological Importance of the Endothelin-1/ET(B) Receptor System on Vascular DiseasesLongitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells
P2860
Q33612103-DF156845-9B12-4501-B9FC-BE55272587BBQ33687215-9F74F70E-F89E-46DE-9DFC-C3A3F0DF9977Q33700596-7155746C-E467-4BBB-AA9D-01C185659344Q33821586-5153F444-89AF-4C77-A490-8EE7A413E6F1Q33833608-C82681DE-FB16-4361-9A16-0DCDFAB7D137Q34032418-0CB50366-F695-4499-9845-7266FCC711A8Q34183242-E287E489-C43C-494B-B2EB-A600D1B219B8Q34193067-90C8502D-CA3C-46F3-83C5-D9AA9C14F9D6Q34193758-1B8103E7-2977-41B6-A5AF-C2CA644AC0DBQ34660400-E99B964B-58EF-4A9C-BAA8-E0C3063BCF76Q34707823-C6A1F9AF-85D5-418F-BECB-91795670E619Q35703652-9248BA90-A110-40A0-8823-8FA2E0E65189Q36147880-30E7F084-C356-472E-8690-EB801D76FC03Q36519047-62C261A4-7BE7-4600-A4E3-A22D5CAD7B48Q36589449-ECF54BD0-462D-407F-993E-322C64C8E499Q36713568-D718382F-CBAB-485C-9A79-EF191D22716FQ37581816-6E002524-B421-4343-9F52-275F234BBEA6
P2860
Noncontraceptive estrogen use and cardiovascular disease.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Noncontraceptive estrogen use and cardiovascular disease.
@en
Noncontraceptive estrogen use and cardiovascular disease.
@nl
type
label
Noncontraceptive estrogen use and cardiovascular disease.
@en
Noncontraceptive estrogen use and cardiovascular disease.
@nl
prefLabel
Noncontraceptive estrogen use and cardiovascular disease.
@en
Noncontraceptive estrogen use and cardiovascular disease.
@nl
P1476
Noncontraceptive estrogen use and cardiovascular disease.
@en
P2093
P304
P577
1985-01-01T00:00:00Z